Marcia Frellick ANAHEIM, California — Gargling and nasal rinsing with saltwater several times a day appeared to be associated with significantly lower COVID-19 hospitalization rates in a small, randomized, double-blind, controlled study. “The hypothesis was that interventions that target the upper respiratory tract may reduce the frequency and duration of upper respiratory symptoms associated with...
Tag: <span>hospitalization</span>
Post
Surprise leading causes of excess hospitalization for people with type 2 diabetes
by Catherine Butterfield, Baker Heart and Diabetes Institute Credit: Unsplash/CC0 Public Domain Findings from a new study reveal that some unexpected conditions are leading to more hospitalizations in people living with type 2 diabetes compared to the general population. The emergence of iron deficiency anemia, mental health disorders and gastrointestinal disorders as leading reasons for...
Post
Pfizer COVID-19 third dose vaccine protection against hospitalization from omicron wanes after 3 months: study
by Kaiser Permanente Credit: Unsplash/CC0 Public Domain A study released April 22 in The Lancet Respiratory Medicine shows that a booster dose of the Pfizer COVID-19 vaccine provides strong protection, roughly 80% to 90%, in the first few months against hospital admissions and emergency department visits caused by the delta and omicron variants. However, against omicron, this...
Post
Stem cell therapy for heart failure reduced major CV events and death, not hospitalization
AMERICAN HEART ASSOCIATION DALLAS, Nov. 14, 2021 — Stem cell therapy helped to reduce the number of heart attacks, strokes, and death among people with chronic, high-risk, NYHA class II or III heart failure with reduced ejection fraction (HFrEF), especially among those who have higher levels of inflammation, yet hospitalization was not reduced, according to...
Post
Increased Risk for Hospitalization, Death with Parkinson’s Drug
Pimavanserin, a novel antipsychotic drug used to manage hallucinations and delusions in Parkinson’s disease, may lead to increased hospitalizations and deaths, according to a new study. A retrospective cohort study of elderly patients with Parkinson’s disease who were in long-term care facilities found that the use of pimavanserin (Nuplazid) was associated with an increased risk of...
Post
FDA authorizes third Covid antibody treatment that cuts risk of hospitalization or death by 85%
By MANSUR SHAHEEN FOR DAILYMAIL.COM PUBLISHED: 18:04 EDT, 27 May 2021 | UPDATED: 18:05 EDT, 27 May 2021 The U.S. Food and Drug Administration (FDA) has authorized the third monoclonal antibody drug to treat COVID-19. Sotrovimab, which was developed by Vir Biotechnology Inc. and GlaxoSmithKline PLC, is believed to able to reduce COVID-19 hospitalizations and deaths by up to 85 percent. It...